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Abstract
Cytomegalovirus (CMV) infection elicits a very strong and sustained intravascular T cell
immune response which may contribute towards development of accelerated immune senes-
cence and vascular disease in older people. Virus-specific CD8+ T cell responses have been
investigated extensively through the use of HLA-peptide tetramers but much less is known
regarding CMV-specific CD4+ T cells. We used a range of HLA class II-peptide tetramers to
investigate the phenotypic and transcriptional profile of CMV-specific CD4+ T cells within
healthy donors. We show that such cells comprise an average of 0.45% of the CD4+ T cell
pool and can reach up to 24% in some individuals (range 0.01–24%). CMV-specific CD4+ T
cells display a highly differentiated effector memory phenotype and express a range of cyto-
kines, dominated by dual TNF-α and IFN-γ expression, although substantial populations
which express IL-4 were seen in some donors. Microarray analysis and phenotypic expres-
sion revealed a profile of unique features. These include the expression of CX3CR1, which
would direct cells towards fractalkine on activated endothelium, and the β2-adrenergic recep-
tor, which could permit rapid response to stress. CMV-specific CD4+ T cells display an
intense cytotoxic profile with high level expression of granzyme B and perforin, a pattern
which increases further during aging. In addition CMV-specific CD4+ T cells demonstrate
strong cytotoxic activity against antigen-loaded target cells when isolated directly ex vivo. PD-
1 expression is present on 47% of cells but both the intensity and distribution of the inhibitory
receptor is reduced in older people. These findings reveal the marked accumulation and
unique phenotype of CMV-specific CD4+ T cells and indicate how such T cells may contribute
to the vascular complications associated with CMV in older people.
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Author Summary
Cytomegalovirus (CMV) is a member of the herpesvirus family and most humans carry
chronic CMV infection. This drives the development of large expansions of CD8+ CMV-
specific T cells, which increase further during ageing. CMV infection is associated with
vascular disease and increased risk of mortality in older people, which may be related to
damage from this CMV-specific immune response. Here we used a set of novel reagents
called HLA class II tetramers to make a detailed study of CMV-specific CD4+ T cells. We
show that CMV-specific CD4+ T cells are found at remarkably high frequencies within
blood, representing up to a quarter of all such white cells. In addition they demonstrate a
range of unique features. Firstly they carry a chemokine receptor that directs the cells to
activated endothelial cells within blood vessels. Secondly, they express epinephrine recep-
tors which would allow them to respond rapidly to stress. Finally, these CD4+ T cells are
unique as they are strongly cytotoxic and equipped with the ability to directly kill virally-
infected cells. HLA class II tetramers therefore reveal a profile of unique features which
provide insight into how CMV-specific CD4+ T cells may be involved in vascular
immunopathology.
Introduction
The effective control of infectious agents requires a range of different arms of the immune sys-
tem. CD4+ T cells play a pivotal role in orchestrating these events, including support for both
antibody production and the expansion and effector function of CD8+ T cells. However it is
now well established that CD4+ T cells can also exert crucial effector functions which may be
mediated by cytokine production or direct cytotoxicity [1–4]. In chronic viral infections such
as cytomegalovirus (CMV) these effector functions are important for control of lytic replica-
tion and suppression of viral reactivation. Human leukocyte antigen (HLA) class I tetramers
have made a huge contribution to the study of antigen-specific CD8+ T cell immune responses
through their ability to allow the visualisation and phenotypic analysis of cells isolated directly
from blood and tissue [5]. In contrast, the study of antigen-specific CD4+ T cells has been lim-
ited by the relative lack of HLA class II tetramers. Although virus-specific CD4+ T cells can be
detected relatively easily by their functional response following exposure to antigen, this alters
their phenotype and transcriptome and does not permit analysis of the resting cellular profile.
As such, much less is known about the profile and function of antigen-specific CD4+ T cells.
CMV is a β-herpesvirus that establishes a lifelong chronic infection and which is well con-
trolled in healthy people. Initial infection leads to the expansion of very large numbers of virus-
specific T cells within peripheral blood which are maintained throughout life and increase even
further with age [6–8]. The virus has evolved multiple mechanisms to evade HLA class I and class
II-restricted T cell immune responses and a state of functional latency is established after infec-
tion, which is associated with intermittent episodes of viral replication (reviewed in [9,10]). HLA
class I tetramers have revolutionized the study of the CMV-specific CD8+ immune response and
have been pivotal in defining the unique immunodominance of the virus, the phenotype of virus-
specific cells and unique aspects of their transcriptome [11]. CMV-specific CD4+ T cells are also
critical effector populations in the control of CMV infection where they maintain function of
virus-specific CD8+ T cells and suppress viral replication at specific tissue sites [12–17]. Indeed,
delayed reconstitution of CMV-specific CD4+ T cells correlates with viral reactivation and CMV
disease in organ transplant recipients and is associated with prolonged urinary viral shedding in
children undergoing primary infection [18]. In relation to murine CMV, mice lacking CD4+ T
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cells are impaired in their ability to clear virus from the salivary gland which is an important site
of viral latency [19,20].
CMV-specific CD4+ T cells have been identified in vitro using cell culture and epitope screen-
ing technology. Indeed, the use of peptide pools spanning the whole viral proteome has shown a
very broad and strong CD4+ T cell response against many viral proteins of which the most
immunodominant are glycoprotein B (gB) and the major tegument component phosphoprotein
65 (pp65) [21]. These studies have shown that the CMV-specific CD4+ T cell response is of
unusually strong magnitude and increases further during ageing [15,22–24]. However, such anal-
yses have relied on the interrogation of cells that have been stimulated with antigen for several
hours prior to analysis and the almost complete absence of HLA class II tetramers has greatly
limited the ability to determine the profile of virus-specific CD4+ T cells directly ex vivo.
HLA class II tetramers have recently been used to identify T cells recognising influenza
[25,26], hepatitis C virus [27,28], HIV [29] and Epstein-Barr virus [30]. Here we have used
three HLA class II tetramers to carry out the first comprehensive analysis of the phenotypic
and transcriptional profile of unmanipulated CMV-specific CD4+ T cells. We show that
CMV-specific CD4+ T cells are found at very high frequencies within peripheral blood, exhibit
a highly differentiated and cytotoxic phenotype which would target them to activated endothe-
lium through CX3CR1-fractalkine binding. These features reveal the extraordinary magnitude
of the CMV-specific CD4+ T cell pool that must be maintained to suppress viral reactivation
and indicate potential mechanisms that may underlie the development of vascular disease dur-
ing chronic CMV infection.
Results
HLA class II tetramers identify expanded populations of CMV-specific
CD4+ T cells during chronic infection of healthy donors
Glycoprotein B and pp65 are the two most immunodominant target proteins for CMV-specific
CD4+ T cells. We obtained HLA-peptide tetramers that contained three epitopes derived from
gB or pp65, the gB-derived DYSNTHSTRYV peptide restricted by HLA-DRB107:01 (DR7) as
well as two pp65-derived epitopes, AGILARNLVPMVATV and LLQTGIHVRVSQPSL, which
are restricted by HLA-DRB302:02 (DR52b) and HLA-DQB106:02 (DQ6) respectively
(Table 1). These epitopes are subsequently named by the first three amino acids of their respec-
tive peptide sequence throughout this paper.
To confirm the specificity of all three tetramers we initially used the reagents to stain CD4+
T cell clones specific for the cognate HLA class II-peptide complex. This confirmed strong and
specific binding whilst very little background was observed following staining of peripheral
blood molecular cells (PBMCs) from CMV-seronegative individuals who expressed the appro-
priate HLA allele contained within each tetramer (Fig 1). The sensitivity of detection of virus-
specific T cells through use of tetramer staining was defined by mixing aliquots of peptide-spe-
cific T cell clone (5%, 1%, 0.5%, 0.25% and 0.1%) with PBMCs taken from a CMV-seronegative
individual. This approach showed that CMV-specific T cells could be identified reliably at fre-
quencies as low as 0.01–0.05% of the total CD4+ T cell population (Fig 1A)
We next went on to use the HLA class II tetramers to enumerate CMV-specific CD4+ T
cells within the peripheral blood of healthy donors. PBMCs were isolated from 73 CMV-sero-
positive individuals between the age of 24 and 88 years who all expressed the appropriate HLA
class II allele contained within the tetramer (Table 1). These were then stained directly with the
HLA class II tetramer and analysed by flow cytometry (Fig 1B and 1C). CMV-specific CD4+ T
cells were observed in 74% of the donors that were tested. The median frequency of CMV-spe-
cific CD4+ T cells was 0.45% of the total CD4+ subset, and this varied between 0.75%, 0.21%
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and 0.66% for T cells specific for the LLQ, AGI and DYS epitopes respectively. The proportion
of CD4+ epitope-specific T cells ranged from 0.01% up to a remarkable value of 24% of all
CD4+ T cells within one individual. Interestingly, 26% of the donors (19/73) carried peptide-
specific T cell populations representing over 1% of the total CD4+ T cell pool.
An increase in the number of CMV-specific CD8+ T cells in association with aging, some-
times termed ‘memory inflation’, has been demonstrated through the use of HLA-peptide tetra-
mer staining. We therefore analysed the frequency of virus-specific CD4+ T cells in relation to
age (Fig 1D). Although the very largest tetramer-staining populations were indeed identified in
the older donors in our study, no clear increase in CMV-specific CD4+ T cells was observed with
age as many younger donors also carried substantial frequencies of CMV-specific CD4+ T cells.
CMV-specific T cells have been detected previously by Interferon (IFN)-γ production fol-
lowing antigen stimulation [23,31] and we were interested to compare the relative number of
CD4+ T cells identified by HLA class II tetramers compared to this functional response. Analy-
sis of intracellular cytokine staining (ICS) for IFN-γ production after stimulation with CMV
peptide was therefore performed within a panel of donors. A strong correlation was observed
between these two values (rSpearman = 0.83; p = 0.008; Fig 1E) although it was of interest that
the number of cells detected by tetramer staining was greater than the value obtained by cyto-
kine detection. This indicates that both the number of virus-specific cells has been underesti-
mated in previous studies using cytokine detection and that peptide-specific T cells display
other functional responses in addition to production of IFN-γ.
CMV-specific CD4+ T cells display a multifunctional profile
To further investigate the functional properties of CMV-specific CD4+ T cells following activa-
tion, we next went on to stimulate PBMCs with peptide prior to assessment of the profile of
cytokine production using ICS. The predominant expression pattern was of combined IFN-γ,
TNF-α and MIP-1β (CCL4) production, with a further subset which failed to generate MIP-1β
(Fig 2). Of note, the proportion of TNF-α+ cells in most donors exceeded that of IFN-γ+ cells.
Interestingly, in three individuals the proportion of IFN-γ+ cells was only between 36–65%
and large populations of cells were observed which produced IL-4, usually in isolation and
Table 1. Details about the HLA class II tetramers used in the study (antigen source, peptide sequence and HLA allele) and the donor cohort.
DYS:DR7 AGI:DR52b LLQ:DQ6
antigen glycoprotein B pp65 pp65
peptide sequencea DYSNTHSTRYV AGILARNLVPMVATV LLQTGIHVRVSQPSL
coordinates 217–227 489–503 41–55
HLA-restriction DRB1*07:01 DRB3*02:02 DQB1*06:02
number of donors: 33 30 23
CMV-speciﬁc T cells detected in: 29 (87.9%) 17 (56.7%) 10 (43.5%)
median frequency (range) [% of CD4+]: 0.66 (0.05–11.75) 0.21 (0.01–2.97) 0.75 (0.09–24.02)
average age in years (range) 50 (25–87) 52 (24–88) 58 (24–87)
male: female 17:16 16:14 8:15
number of donors per age groupb:
young: 20-40yrs 11 (11) 7 (3) 3 (2)
middle aged: 41–60 yrs 13 (9) 14 (12) 10 (6)
older adults: over 60 yrs 9 (9) 8 (2) 9 (2)
aEpitopes are named referring to the ﬁrst three amino acids of their peptide sequence (underlined)
bin brackets number of donors tetramer+ cells were detected in
doi:10.1371/journal.ppat.1005832.t001
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sometimes in combination with other cytokines. Indeed, in one donor these comprised up to
60% of peptide-specific cells. Virtually no CMV-specific CD4+ T cells produced IL-17A or IL-
10 in response to antigen stimulation and no significant differences were observed between T
cells recognising the gB or pp65-derived epitopes.
CMV-specific T cells display a unique pattern of CD4+ T cell
differentiation
We next undertook a more detailed analysis of the phenotype of CMV-specific CD4+ T cells.
Expression of CCR7 and CD45RA was used to define naïve, central memory (CM), effector
Fig 1. Detection of CMV-specific CD4+ T cells in healthy virus carriers using HLA class II tetramers. (A)
Specificity of HLA class II tetramers was tested by staining HLA-matched PBMCs of a CMV seronegative donor and
an epitope-specific T cell clone (representative example shown for DYS:DR7). At the same time sensitivity of the
tetramer reagents was tested by mixing decreasing numbers of the clonal T cells with PBMCs of the CMV-
seronegative donor. Plots are representative of two independent experiments. Similar results were obtained for all
three HLA class II tetramers tested. (B) Representative examples of healthy donor PBMCs stained with each of the
three HLA-peptide tetramers used in this study. Background staining without tetramer is very low and examples are
shown of epitope-specific T cells at low, intermediate and high frequencies. Numbers indicate the proportion of
tetramer+ (TM+) cells within the total CD4+ T cell population. (C) Summary of all data for all individuals tested in this
study depicting frequency of TM+ cells within the total CD4+ T cell population for each epitope and (D) the correlation
between frequency of TM+ cells and donor age (n = 56). (E) The frequency of cells detected by tetramer staining
correlates strongly with the proportion of IFN-γ producing cells detected by intracellular cytokine staining following
stimulation with the cognate peptide. Spearman‘s rank correlations were performed to measure the strength of
associations between variables (D and E).
doi:10.1371/journal.ppat.1005832.g001
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memory (EM) and revertant CD45RA+ effector memory (EMRA) cells. A median of 88% of
CMV-specific CD4+ T cells displayed an EM phenotype (CCR7-CD45RA-) with only 3.3% of
cells expressing a CCR7+CD45RA- profile typical of CM cells (Fig 3A). In addition, re-expres-
sion of CD45RA was found on only a minor subset (1.8%) of effector memory cells, in marked
contrast to the profile observed commonly on CMV-specific CD8+ T cells [6]. The surface
expression of the additional differentiation markers CD27, CD28, CD57 and CD45RO was
then assessed in order to undertake a more detailed phenotypic analysis. A Boolean gating
strategy was used to investigate expression patterns of these markers and determine the differenti-
ation hierarchy of the CMV-specific CD4+ T cells (Fig 3B). As anticipated, the majority of the
global CD4+ T cell population in each donor expressed a naïve phenotype but CM and EM popu-
lations were also observed in comparable proportions (S1 Fig). The differentiation pattern of the
CMV-specific T cells was very different (Fig 3B) and this, when combined with current under-
standing of T cell biology [32,33], allowed us to model the profile of CMV-specific CD4+ T cell
differentiation (Fig 3D). This revealed that CMV-specific CD4+ T cells can be detected in several
stages of differentiation and reveals progression through a dual CD45RA+CD45RO+ stage prior
to loss of CD45RA expression and attainment of CCR7+CD45RO+ central memory phenotype.
Further differentiation led to downregulation of CCR7 followed by a sequential loss of CD27 and
CD28 expression. Indeed, 64% of cells exhibited a predominant CD27-CD28- profile whereas
22% (12/55) displayed a largely CD27-CD28+ profile. CD57 expression is a predominant feature
of CMV-specific T cells and was observed almost exclusively on CD27-CD28- cells, with minor
expression on the CD27-CD28+ population. A final stage of differentiation, in a minority of cells,
was the re-expression of CD45RA which coincided with complete loss of CD45RO expression.
Further examination of virus-specific populations within individual donors revealed a mod-
erate degree of heterogeneity in relation to differentiation status. Indeed it was noteworthy that
9% (5/55) of responses were characterised by a dominant central memory phenotype whilst
only 3 responses exhibited late stage CD45RA+ effector memory (EMRA) differentiation (Fig
3B). As such we next went on to examine potential factors that might be related to the
Fig 2. Functional characterisation of CMV-specific CD4+ T cells. Following peptide stimulation of PBMCs
the cytokine profile of activated CD4+ T cells was analysed using multicolour flow cytometry. Pie charts in the
top summarise the data for gB (DYS)- and pp65-specific T cells (AGI and LLQ), each arc representing one of
the cytokines studied, and showing the proportion of responding cells making them. The bottom graph shows
individual responses and the proportion of cells detected in relevant different functional subsets.
doi:10.1371/journal.ppat.1005832.g002
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differentiation profile of virus-specific CD4+ T cells. Interestingly, this was not correlated with
the magnitude of the immune response, a pattern that is different to the profile for virus-spe-
cific CD8+ T cells where clonal expansion is associated with a greater degree of differentiation
Fig 3. Phenotype of CMV-specific CD4+ T cells. (A) The memory phenotype of virus-specific T cells was determined
initially using co-expression patterns of CCR7 and CD45RA (n = 56). Bars represent median with interquartile range. The
cells were then further characterised by staining with CCR7, CD27, CD28, CD57, CD45RA and CD45RO. (B) Using
Boolean gating all possible combinations of the six surface markers were determined and cells were categorised according
to differentiation status, with the least differentiated subset on the left. The heatmap represents data for each individual
response, showing the proportion of tetramer positive (TM+) cells within each subset (% of TM+ cells, scale bar at the top).
Labelled to the right are the number of the donor and in brackets the peptide epitope and frequency of TM+ cells. (C) We
then examined and compared expression patterns between T cells specific for all three CMV-derived epitopes. Each pie
chart summarises data for one of the epitopes studied, arcs representing the proportion of TM+ cells expressing any
particular marker. To compare T cells specific for the different epitopes (pie charts) permutation analysis (non-parametric
test) was performed in SPICE. (D) Proposed stages of differentiation of CMV-specific CD4+ T cells.
doi:10.1371/journal.ppat.1005832.g003
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[6]. In contrast, antigenic specificity may be an important factor as CD4+ T cells specific for
DYS (glycoprotein B) displayed a more differentiated phenotype compared to pp65-specific T
cells (Fig 3C). As such, loss of CD28 or gain of CD57 expression was seen on 62% and 41% of
gB-specific T cells respectively, compared to only 30% and 18% of CD4+ T cells specific for the
epitopes from pp65. Moreover, an EMRA phenotype was observed only on the CD4+ T cells
which were specific for DYS.
The availability of HLA-peptide tetramers allows the direct analysis of antigen-specific T
cells without prior stimulation and this was felt to be particularly valuable in the assessment of
CD4+ T regulatory function as FoxP3 expression can be induced following activation through
the TCR [34]. In order to investigate whether CMV-specific CD4+ T cells contain natural T
regulatory cells we stained cells directly ex vivo with HLA class II tetramer, anti-CD4, anti-
CD25, anti-CD127 and intracellular anti-FoxP3. However, virtually no CMV-specific T cells
were found to exhibit a CD4+CD25+CD127low/-FoxP3+ T regulatory phenotype (S2 Fig).
Transcriptional analysis of CMV-specific CD4+ T cells reveals high level
expression of genes associated with cytotoxicity and chemotaxis
The availability of HLA class II-peptide tetramers allowed us to undertake direct purification
and transcriptional analysis of CMV-specific CD4+ T cells, an approach that has been impor-
tant in relation to determining novel features of the equivalent CD8+ T cell subset [11]. CMV-
specific CD4+ T cells were isolated from the blood of five CMV-seropositive donors by staining
with tetramer followed by high purity cell sorting. Two of these populations were specific for
epitope DYS and three recognised the peptide LLQ. Effector memory T cells isolated from
CMV seronegative individuals were used as a comparator group.
The pattern of normalised gene expression was compared initially between the combined
transcriptome of the CMV-specific T cell samples and the effector memory population from
CMV-negative donors. Global expression patterns were broadly similar between the two
groups, reflecting the shared effector memory phenotype. However 55 mRNA transcripts dif-
fered by at least two-fold expression between the two groups, of which 35 were upregulated in
CMV-specific T cells and 20 genes were lower within this group (Fig 4A and S1 Table). We
also compared the individual transcriptional profiles of DYS- and LLQ-specific T cell popula-
tions and here 12 of the 55 genes that exhibited differential expression between the combined
profile of CMV-specific and control EM cells were also differentially expressed in both the
DYS- and LLQ-specific T cells. 36 genes were altered only within the DYS-specific populations
and 7 genes exhibited differential regulation within LLQ-specific T cells alone (Fig 4B, S2 and
S3 Tables), probably reflecting the more marked differentiation profile observed for the DYS-
specific population. Relative expression levels (aquantile normalised expression) for selected
transcripts are depicted in Fig 4C comparing DYS and LLQ-specific CD4+ T cells, as well as
CD4+ EM cells from CMV seronegative donors. An increase in relative transcription levels
was often observed for LLQ-specific T cells which was then further enhanced in DYS-specific
T cells explaining why more significant differences in gene expression were observed in com-
parisons between DYS-specific T cells only and EM T cells.
The function of many proteins encoded from the genes upregulated in CMV-specific T cells
is related to cytotoxic function, such as granzymes B, H and A, granulysin and perforin.
Expression of the chemokines CCL3 (MIP-1α) and CCL4 (MIP-1β) was strongly increased
and indicates an important role for CMV-specific CD4+ T cells in attracting cells of the innate
immune system to the site of viral recognition. The increased pattern of transcription of
CX3CR1 in DYS-specific T cells is of particular note as this chemokine receptor has been
shown to be a discriminative marker for CMV-specific CD8+ T cells and is thought to attract
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cells to areas of stressed endothelium which express the membrane-bound ligand fractalkine
[11]. In addition we observed marked overexpression of ADRB2, the gene encoding the
β2-adrenergic receptor, on these cells which forms an important link between the sympathetic
nervous system and the immune system. Additional upregulated genes of interest in CMV-spe-
cific T cells included the G protein coupled-receptor GPR56 and fibroblast growth factor-bind-
ing protein 2 (FGFBP2), both of which have been previously associated with cytotoxic activity,
and the secreted extracellular matrix protein SPON2. As changes in level of transcription do
not always translate into the same changes at protein level, further analysis would be needed to
confirm some of these observations.
Fig 4. Transcriptional analysis of CMV-specific T cells. (A) CD4+ T cells specific for gB-derived epitope DYS and pp65-derived epitope LLQ were
sorted as well as EM CD4+ T cells (CCR7-CD45RA-) of CMV-seronegative individuals and the mRNA transcriptional profile determined using
microarray analysis. Transcription of 55 genes was at least 2-fold up or downregulated in CMV-specific T cells compared to the EM cells, which is
graphically presented here. (B) The Venn diagram summarises differences observed between EM cells and T cells specific for the two CMV-derived
epitopes. (C) Relative transcript levels of aquantile normalised data are depicted for selected genes, comparing EM, LLQ- and DYS-specific T cells. (D)
qPCR analysis was performed for genes identified as showing transcriptional upregulation in the microarray analysis. Gene expression levels in TM+
cells were related to those in CD4+ EM cells. Analysis was performed in 2–3 individuals in duplicate. Bars represent means with SEM, Kruskal-Wallis
test was performed with Dunn‘s multiple comparison in GraphPad Prism5 to derive p-values.
doi:10.1371/journal.ppat.1005832.g004
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Several genes were downregulated in CMV-specific T cells of which the most striking pat-
tern was seen for ADAMTS6, a member of the ADAMTS family (a disintegrin and metallopro-
teinases with thrombospondin). These secreted proteins have roles in mediating cell adhesion
and proteolytic shedding and it is of interest that ADAMTS6 expression is increased by TNF-α
[35]. The physiological importance of this will require further investigation as the substrate for
ADAMTS6 is currently unknown. CD27 expression was also reduced, reflecting its marked
reduction at the cell surface, and levels of TNFRSF4 (OX40) transcript, which is induced fol-
lowing cell activation, was also low suggesting that CMV-specific CD4+ T cells are largely rest-
ing in the steady state.
To further validate results from the microarray analysis, and investigate differences observed
between LLQ- and DYS-specific CD4+ T cells, we performed qPCR analysis for genes that were
found to exhibit differential expression on microarray. These include the chemokines CCL3,
CCL4 and CCL5, GZMB and perforin, as well as CX3CR1 and the ADRB2 gene. For all seven
genes we confirmed increased levels of transcription in CMV-specific T cells compared to the
CD4+EM population (Fig 4D). The pattern of expression was broadly reflective of that seen in
the microarray analysis. Particularly high transcript levels in CMV-specific T cells were observed
for GZMB (30 to 50-fold increase), CCL4 (6 to 19-fold increase) and CX3CR1. Of note, in DYS-
specific T cells transcription of CX3CR1 was found to be 1000-fold higher than in EM cells and
levels were also 12-fold higher in LLQ-specific T cells. Gene expression of ADRB2 was also
increased in both LLQ- and DYS-specific T cells.
CMV-specific CD4+ T cells demonstrate strong cytotoxic potential, high
level expression of CX3CR1 and are capable of direct killing of target
cells
We next went on to investigate the protein expression of four genes whose transcription had
been revealed to be strongly upregulated by microarray analysis. As such, tetramer staining
was combined with antibodies to granzyme B, perforin, FasL and CX3CR1. CMV-specific
CD4+ T cells were found to possess a very strong cytotoxic phenotype with up to 96% of cells
staining positive for granzyme B on direct ex vivo analysis (Fig 5A). This pattern was particu-
larly strong for glycoprotein B-derived DYS-specific T cells which exhibited a median expres-
sion level of 78%, compared to 61% and 45% of the pp65-derived LLQ- and AGI-specific T
cells respectively. Perforin expression was also found on 57%, 39% and 27% of these three pop-
ulations respectively and all T cells that expressed perforin showed co-expression of granzyme
B. A very strong correlation was observed in relation to the expression of CX3CR1 with cells of
a cytotoxic phenotype (Fig 5A). In CMV seronegative individuals the proportion of CD4+ EM
T cells expressing markers of cytotoxicity was only around 1%.
Given the clinical importance of CMV infection in older people we further analysed the
expression of granzyme B, perforin and CX3CR1 in relation to the age of the donor (Fig 5B).
Interestingly, the substantial cytotoxic potential of CMV-specific CD4+ T cells was found to
increase even further with aging and this was particularly the case for pp65-specific T cells,
within which perforin expression increased from 18% within donors aged 20–35 years com-
pared to 43% in those aged over 60 years. The cytotoxic profile of DYS-specific T cells also
tends to increase with age but this effect was less marked as the cytotoxic phenotype was
already strongly established in these cells at an early age. The expression of CX3CR1 was con-
sistently high on CMV-specific T cells from donors at all age groups with 80–90% of both gB
and pp65-specific cells carrying this receptor. Expression of FasL was detected on only a very
small proportion of CD4+ T cells, with a median of 0.7% of CMV-specific cells and 0.48% of
the global effector memory CD4+ pool expressing this marker (S3 Fig).
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To investigate whether CMV-specific CD4+ T cells are indeed capable of killing target cells
directly ex vivo, we isolated virus-specific cells from peripheral blood using tetramers and deter-
mined lysis of autologous or HLA-matched lymphoblastoid cell lines (LCLs) loaded with cognate
peptide. CD4+ effector memory T cells (CCR7-CD45RA-) from two CMV-seronegative individ-
uals were selected as controls. CMV-specific CD4+ T cells displayed remarkable cytotoxic capac-
ity and this was seen for cells specific for all three peptide targets (Fig 5C). At an effector:target
Fig 5. CMV-specific CD4+ T cells are highly cytotoxic directly ex vivo. PBMCs were stained with LIVE/
DEAD fixable dye, before staining with HLA class II tetramer followed by anti-CD3, CD4 and CX3CR1. After
fixation and permeabilisation Granzyme B and Perforin were stained intracellularly. (A) Pie charts represent
the proportion of CD4+ EM T cells (in CMV seronegative individuals) or the TM+ population expressing the
indicated markers and combinations thereof. To compare pie charts permutation analysis was performed in
SPICE. (B) Expression of Granzyme B, perforin and CX3CR1 on pp65-specific (on the left) and gB-specific
(on the right) T cells in relation to donor age. Spearman‘s rank correlation was used to analyse the strength of
associations between variables. (C) Percentage killing of peptide-loaded target cells (HLA-matched LCLs)
mediated by ex vivo separated CD4+TM+ or CD4+EM T cells following over night co-culture at effector:target
(E:T) ratios indicated. All conditions were performed in triplicate; bars represent means with SEM. (D)
Proportion of cells expressing NKG2D within the CD4+ EM or the CMV-specific T cell population in young,
middle aged or older adults. Error bars represent medians and IQR. p-values: ** p = 0.001–0.01, ***
p = 0.001–0.0001. Kruskal-Wallis test was performed with Dunn‘s multiple comparison in GraphPad Prism5
to derive p-values.
doi:10.1371/journal.ppat.1005832.g005
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(E:T) ratio of 1:1 LLQ- and AGI-specific T cells lysed around 77% of target cells within 20 hours.
DYS-specific T cells were able to kill 56% of target cells even at an E:T ratio of 0.5:1. No killing
was observed by CD4+EM cells isolated from CMV seronegative individuals.
Previous studies have shown that CMV-specific CD4+T cells can express the co-stimulatory
molecule NKG2D [36] which is almost always present on cytotoxic NK cells and CD8+ T cells.
However these analyses relied on functional activation with viral antigen and we therefore examined
NKG2D expression on unmanipulated cells through the use of HLA class II tetramers. Interestingly,
NKG2D expression was negligible on the CD4+ EMT cell population in CMV seronegative indi-
viduals, with a median expression of only 0.66%, but was observed on 23% of CMV-specific CD4
+ T cells (Fig 5D). Importantly, this proportion did not show any increase in relation to aging.
CMV-specific CD4+ T cells express high levels of the inhibitory molecule
PD-1
Relatively little is known about the pattern of expression of inhibitory markers such as PD-1 or
Tim-3 on antigen-specific CD4+ T cells. Expression of PD-1 on virus-specific CD8+ T cells has
been associated with functional impairment of immune responses against HIV or HCV, both
chronic infections in which antigen load may remain high for prolonged periods of time
[37,38]. However in healthy individuals PD-1hi CD8+ T cells usually demonstrate an effector
memory phenotype and do not necessarily exhibit functional ‘exhaustion’ [39].
To get a better understanding of PD-1 expression on CD4+ T cell populations we initially
analysed the memory phenotype of PD-1+ cells within the global CD4+ T cell subset and the
CMV-specific T cell population. This showed that within the CD4+ T cell population 62% of
PD-1+ cells carried an EM phenotype and 22% were CM cells (Fig 6A). Of the PD-1+ CMV-
specific CD4+ T cells 94% displayed a CCR7-CD45RA- EM phenotype and virtually no cells
had a CCR7+CD45RA-CM phenotype (Fig 6B).
We therefore examined the pattern of expression of PD-1 on CMV-specific CD4+ T cells
and contrasted this with the pattern of staining on the CD4+EM T cell population. PD-1
expression was observed on a median 47% of CMV-specific CD4+ T cells and exhibited a
remarkable range of expression, with cells from some donors showing hardly any evidence of
PD-1 expression whereas virtually 100% of cells were positive in other individuals (Fig 6C).
When PD-1 expression was evaluated in relation to peptide specificity it was clear that PD-1
expression was markedly reduced on DYS-specific CD4+ T cells, where it was observed on
29% of virus-specific cells, compared to 51% and 47% of AGI- or LLQ-specific T cells, respec-
tively. Interestingly, PD-1 expression was very low on the CD4+EM T cell population and was
observed on less than 10% of cells (Fig 6C). When analysing the median fluorescence intensity
(MFI) of PD-1 on these cell populations we found the same trends within virus-specific T cells,
and much lower MFI values were detected on CD4+EM T cells (Fig 6D). Of interest, Tim-3
expression was not detected on a significant proportion of any CD4+ T cells (S4 Fig).
It might be anticipated that the proportion of T cells expressing an inhibitory marker would
increase with age. Therefore we examined both the percentage of PD-1+ cells and the MFI of
PD-1 expression on CMV-specific T cells, and the CD4+EM T cell subset, in relation to age.
The proportion of PD-1+ cells did not change in relation to the age of the donor (Fig 6E) how-
ever a non-significant trend was observed towards lower levels of PD-1 protein expression
(MFI) on the surface of PD-1+ CMV-specific CD4+ T cells in older adults (Fig 6F).
Discussion
In this study we have used HLA class II-peptide tetramers to identify and characterise CMV-
specific CD4+ T cells, without the need for functional identification, for the first time. This
Analysis of CMV-Specific CD4+ T Cells Using Tetramers
PLOS Pathogens | DOI:10.1371/journal.ppat.1005832 September 8, 2016 12 / 25
allowed a comprehensive analysis of the resting phenotype and transcriptional profile of anti-
gen-specific CD4+ T cells recognising glycoprotein B and pp65, the two viral proteins recog-
nised most frequently by CMV-specific CD4+ T cells [21]. The CD4+ T cell response against
cytomegalovirus is of interest for several reasons, related primarily to the unusual magnitude
and phenotype of virus-specific cells, and also their potential role in the vascular damage that is
reported in association with CMV infection in older people [40,41]. Here we identified CMV
epitope-specific responses ranging from 0.01% up to a remarkable 24% of the total CD4+ reper-
toire. The median peptide-specific response was 0.45% of the CD4+ T cell repertoire which is
considerably higher than CD4+ T cell responses against viruses such as influenza, hepatitis C
Virus and Epstein-Barr Virus [30,42,43].
Interestingly, the frequency of cells identified by tetrameric staining was greater than that
detected by expression of IFN-γ following peptide stimulation. As such, although this confirms
the strong Th1 profile of CMV-specific CD4+ T cells, it also reveals that a considerable propor-
tion of peptide-specific CD4+ T cells demonstrate an alternative cytokine profile. Indeed, TNF-α
Fig 6. Analysis of inhibitory molecule PD-1 on CMV-specific T cells. PBMCs were stained with LIVE/
DEAD fixeable dye, followed by HLA class II tetramer, before staining to detect surface molecules. (A)
Percentage of PD-1+ cells within T cell memory subsets defined by co-expression of CCR7 and CD45RA for
the total CD4+ population (n = 53). (B) Percentage of PD-1+ cells within those subsets for the TM+ cells
(n = 53). Columns represent medians with IQR. (C) The frequency of PD-1+ cells within the CD4+EM T cell
subset, LLQ-, AGI- and DYS-specific T cell populations. (D) MFI of PD-1 expression on CD4+EM T cells as
well as LLQ-, AGI- and DYS-specific T cells. Error bars indicate medians and IQR. p-values: * p = 0.01–0.05,
** p = 0.001–0.01. Kruskal-Wallis test was performed with Dunn‘s multiple comparison in GraphPad Prism5
to derive p-values (C and D). (E) The proportion of TM+ cells and CD4+EM cells expressing PD-1 in relation
to donor age. (F) Median fluorescence intensity (MFI) of PD-1 expression on TM+ cells and CD4+EM cells
correlated with donor age. Spearman‘s rank correlation was used to analyse the strength of associations
between variables (D and E).
doi:10.1371/journal.ppat.1005832.g006
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was the cytokine most frequently produced by CMV-specific CD4+ T cells. In addition, a propor-
tion of virus-specific T cells was found to secrete IL-4 in some donors although the great majority
of CMV-specific CD4+ T cells display a polarized Th1 phenotype [44]. IL-4 production by
CMV-specific CD4+ T cells has previously been reported through ELISPOT analysis [45]. Of
interest, although IL-4 production within pp65-specific T cells was usually observed with co-ex-
pression with IFN-γ, IL-4 production by gB-specific cells was seen in the absence of other cyto-
kines. As such these observations indicate novel functional roles for IL-4 in the setting of chronic
infection which warrant further investigation [46]. Functional assays using stimulation with
whole viral lysate have demonstrated an increase in virus-specific CD4+ T cells with age [22] and
although a similar trend was observed in our analysis it is likely that demonstration of such T cell
‘memory inflation’ will require analysis of responses directed against a wide range of different
epitopes. Many younger donors already had high frequencies of epitope specific T cells in the
periphery. This may be a reflection of the duration of viral carriage as some individuals acquire
the virus very early in life whereas others only do so at a later time.
Almost all CMV-specific CD4+ T cells expressed an effector memory phenotype, although
in contrast to CMV-specific CD8+ T cells, very few had reverted to re-expression of the
CD45RA isoform rather than CD45RO. In vitro studies suggest that re-expression of CD45RA
occurs during prolonged absence of antigenic stimulation [47] which may indicate that CMV-
specific CD4+ T cells undergo antigen recognition in vivomore frequently than CD8+ subsets.
Latent CMV is maintained within cells of the monocytic lineage and viral reactivation occurs
during maturation into dendritic cells [48]. As such, CMV-specific CD4+ T cells are likely to
undergo regular antigenic stimulation and this may serve to retain expression of the CD45RO
isoform. Tetramer staining also allowed a detailed analysis of the membrane phenotype of
CMV-specific CD4+ T cells and indicated that CD27 expression is lost early during differentia-
tion and is then followed by loss of CD28 in the majority of the population. Loss of CD28
expression on CD4+ T cells is very unusual and, indeed, the CD4+CD28- phenotype is virtually
unique to CMV-specific T cells [49] and indicates that alternative mechanisms of T cell co-
stimulation become important in the CMV-specific immune response, potentially through
molecules such as 4-1BB [50]. CD57 is a poorly characterised molecule, but is again highly spe-
cific for CMV-specific T cells and was found to be expressed reciprocally with CD28, suggest-
ing that it may itself have a potential role in co-stimulation. NKG2D is one such potential
alternative costimulatory molecule and can synergise with TCR-dependent activation of CMV-
specific CD4+ T cells to enhance a range of effector functions [36,51,52]. Indeed, we found that
NKG2D was expressed on 23% of CMV-specific CD4+ T cells, a remarkably high level for a
molecule typically associated with expression on NK and CD8+ T cells. The high degree of dif-
ferentiation seen for CMV-specific CD4+ T cells was largely independent of the frequency of
epitope-specific T cells, indicating that alternative factors, such as the environment in which T
cell priming occurs or the availability of antigen, may influence their phenotypic profile
(reviewed in [53]). However the antigenic specificity of virus-specific CD4+ T cells did have a
marked influence on the differentiation status such that CD4+ T cells specific for glycoprotein
B-derived epitope DYS consistently displayed a more differentiated phenotype
than pp65-specific cells. Glycoprotein B is highly unusual in that it has direct access to the
HLA class II antigen-processing pathway of infected cells. This mechanism is likely to mediate
frequent reactivation of gB-specific T cells and could explain the more ‘driven’ differentiation
phenotype of CD4+ T cells specific for peptides from this protein [54,55].
A unique aspect of our study was the direct isolation of virus-specific CD4+ T cells without
the need for antigenic stimulation, such that we were able to analyse their resting transcrip-
tional profile. Even though differences to CD4+EM T cells of CMV seronegative individuals
were generally modest, the most striking observations were seen in the expression of genes
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related to cytotoxic function and chemotaxis. Remarkably, the profile of cytolytic genes upre-
gulated in CMV-specific CD4+ T cells closely corresponds to the pattern seen in CD8+ cyto-
toxic T cells (CTL). These included granzymes A, B and H, as well as perforin, granulysin and
NKG7. Importantly, we were also able to determine that Fas ligand is not expressed by virus-
specific CD4+ T cells, indicating that the delivery of mediators from cytotoxic granules is the
dominant mechanism of target cell lysis. Remarkably, the use of tetrameric staining reveals
that this profound cytotoxic potential of CMV-specific T cells is observed within resting cells
in the bloodstream. Furthermore isolated virus-specific CD4+ T cells very efficiently kill anti-
gen-loaded target cells directly ex vivo suggesting that they are primed for rapid target cell lysis
in the event of an episode of viral reactivation.
CMV-specific CD4+ T cells also expressed a distinctive profile of chemokines and addi-
tional proteins that indicate an important role in chemotaxis and tissue migration. Indeed, one
of the most fascinating features of CMV-specific CD4+ T cells is their high level of expression
of CX3CR1, a chemokine receptor that binds CX3CL1 (fractalkine) and has already been iden-
tified as a specific marker for CMV-specific CD8+ T cells [11]. The CX3CR1/CX3CL1 axis
plays an important role in both the adhesion and transmigration of lymphocytes to endothelial
cells during inflammation [56,57]. Interestingly, endothelial cells are a principal target tissue
for CMV infection and the expression of CX3CR1 on CMV-specific T cells may therefore act
to localise adaptive immunity to sites of viral reactivation. This mechanism of endothelial-tar-
geting may be highly relevant to the potential development of endothelial immunopathology
mediated by CMV-specific cytotoxic T cells [58,59]. Indeed a close link has been observed
between augmented CMV-specific immune responses and a range of inflammatory conditions
(reviewed in [60]) and the proportion of CD4+CD28- T cells has been shown to correlate
directly with cardiovascular mortality in some studies [61].
CMV-specific CD4+ T cells also exhibit a very similar chemokine secretion profile to that of
virus-specific CD8+ cells, with production of the inflammatory mediators CCL3 (MIP-1α),
CCL4 (MIP-1β) and CCL5 (RANTES), all of which would support recruitment of innate
immune cells such as macrophages and NK cells. The pattern is associated with high level
expression of IFN-γ and TNF-α but very little production of IL-2 [23,62] and is again typical of
a differentiated Th1 profile.
An additional interesting observation from the microarray data was the detection of high
levels of ADRB2mRNA in glycoprotein B-specific T cells. ADRB2 encodes the β2-adrenergic
receptor which allows cells to respond to systemic production of epinephrine and forms an
important link between the sympathetic nervous system and the adaptive immune response
[63,64]. The CMV genome contains promoter elements that can bind epinephrine leading to
increased viral gene transcription [65] and physiological stress is established as a risk factor for
reactivation of many herpesviruses. Interestingly, CX3CR1+ T cells have been shown to be the
major T cell subset released into the circulation following administration of epinephrine, in a
mechanism partially mediated by reversal of their resting adherence to endothelium [66]. This
may provide a mechanism of rapid mobilisation for CMV-specific T cells in response to stress
induced viral reactivation, but this will need further investigation.
T cell activation and effector function are finely tuned events and CD4+ T cells show an
extremely high sensitivity for their cognate antigen [67]. Moreover lytic synapse formation has
a very low threshold for activation [68,69]. A proportion of CD27-CD28- CMV-specific CD4+
T cells has previously been described to exhibit regulatory function in vitro [70] but FoxP3+
cells were not detectable in this study and antigen-specific T cells were not shown to produce
IL-10. This suggests that regulatory mechanisms are likely to be focussed at the level of the
effector T cell and here PD-1/PD-L1 interactions play a key role as a negative feedback mecha-
nism controlling TCR-dependent effector function of T cells [71]. High levels of PD-1 have
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been detected on CD8+ effector memory T cells [39] and similarly we find that PD-1 expres-
sion on CD4+ T cells is also largely confined to this subset. PD-1 expression was seen on nearly
half of all CMV-specific CD4+ T cells and could serve to limit T cell activation. As such it is
noteworthy that the level of membrane PD-1 expression (MFI) on virus-specific CD4+ cells
tends to decrease during aging and may therefore lower the activation threshold of T cells at a
time when their cytotoxic potential is actually increasing. Together these factors may influence
virus-host balance across the life course and may contribute towards immunopathology.
In summary our data reveal that people who are chronically infected with cytomegalovirus,
which represents the great majority of the global population, harbour substantial populations
of virus-specific CD4+ T cells within their bloodstream. These highly differentiated cells dis-
play a strongly cytotoxic phenotype, may be targeted to activated endothelium and have the
potential to respond to physiological ‘stress’ through detection of epinephrine (Fig 7). In addi-
tion, this cytotoxic profile increases further with age whilst the level of inhibitory PD-1 on the
surface declines. These findings reveal the exceptional evolutionary adaptation of the CD4+ T
cell response towards the control of CMV. In addition they shed light on the potential mecha-
nisms whereby CMV infection may serve to mediate tissue damage, most particularly vascular
disease, and indicate a range of potential novel immunotherapeutic targets.
Materials and Methods
Ethics statement
The study was approved by the West Midlands (Black Country) Research Ethics Committee
(REC 07/Q2702/24) and all donors gave written informed consent before participation. The
donor cohort included samples from laboratory personnel, the blood transfusion service and
healthy older adults recruited from the ‘Birmingham 1000 Elders group’ (REC 2002/073).
Fig 7. Potential mechanism of virus-directed vascular injury in response to stress and endothelial
damage. CMV-specific CD4+ T cells expressing β2-adrenergic receptor would be mobilised into the
bloodstream in response to epinephrine released during stress. Epinephrine also leads to reactivation of
virus from latently infected endothelial cells. Furthermore, activation/inflammation of endothelium induces
expression of membrane-bound fractalkine. CX3CR1+ CMV-specific CD4+ T cells would adhere to
endothelium, antigen recognition leading to activation of these highly cytotoxic effector cells and direct killing
of virus-infected endothelial cells. Release of cytokines and chemokines from CMV-specific CD4+ T cells
potentially attracts further immune cells to such sites of viral reactivation and inflammation which may
enhance vascular injury.
doi:10.1371/journal.ppat.1005832.g007
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Study subjects
A total number of 73 CMV-seropositive donors, aged between 24–88 years, with appropriate
HLA-genotype were included in the study. PBMCs were isolated from 50ml heparinized blood
by density gradient centrifugation using Lympholyte-H cell separation media (Cedarlane) and
aliquots of 10x106 cells were cryopreserved in RPMI1640 (Sigma-Aldrich) containing 20% fetal
calf serum (FCS) and 10% DMSO and stored in liquid nitrogen until use.
To identify donors with the appropriate HLA-genotype, genomic DNA was isolated from
PBMCs using the GenElute Blood Genomic DNA Kit (Sigma-Aldrich) according to manufac-
turer’s instructions. Typing for HLA class II alleles was performed by PCR technique as
described previously [72].
HLA class II-peptide tetramer complexes
Phycoerythrin (PE)-conjugated custom-made HLA class II tetrameric complexes were pur-
chased from the Benaroya Research Institute at Virginia Mason (Seattle, Washington). Three
tetramer complexes were used in this study: They were comprised of the CMV gB-derived epi-
tope DYSNTHSTRYV in the context of HLA-DRB107:01 (DR7) [73], or pp65-derived epi-
topes AGILARNNLVPMVATV within HLA-DRB302:02 (DR52b) [74] and
LLQTGIHVRVSQPSL within HLA-DQB106:02 (DQ6) [75].
Initially, the specificity of each tetramer was confirmed by screening against CD4+ T cell
clones recognizing the tetramer’s cognate HLA class II-peptide complex or against PBMCs
from a CMV-seronegative donor expressing the appropriate HLA-allele. Optimal tetramer
concentration and staining times were distinguished at the outset and constant conditions used
throughout the study.
Cell staining and flow cytometric analysis
Surface staining. A total of 1 x 106 PBMCs were stained with LIVE/Dead fixable violet
stain (Invitrogen) for 15 minutes at room temperature (RT), followed by a wash step with
phosphate-buffered saline (PBS). Cells were then re-suspended in 50 μL of human serum and
incubated with PE-conjugated HLA class II tetramer for 1 h at 37°C and 5% CO2. After three
washes with staining buffer (1xPBS supplemented with 0.5% BSA and 2 mM EDTA), the cells
were co-stained for 15 minutes at 4°C with saturating amounts of different combinations of the
following antibodies: anti-CD3 AmCyan (SK7, BD Biosciences), anti-CD4 PerCPCy5.5
(RPA-T4, eBioscience), anti-CD4 PE-CF594 (RPA-T4, BD Biosciences), anti-CD4 APC-Cy7
(RPA-T4, Biolegend), anti-CD14 Pacific Blue (HCD14, Biolegend), anti-CD19 eFluor450
(H1B19, eBioscience), anti-CD25 APC-Cy7 (BC96, Biolegend), anti-CD27 APC-eFluor780
(O323, eBioscience), anti-CD28 PE-Cy7 (28.2, Biolegend), anti-CD45RA AF700 (H1 100, Bio-
legend), anti-CD57 APC (HCD56, Biolegend), anti-CD69 PE-Cy7 (FN50, Biolegend), anti-
CD127 PerCP-Cy5.5 (HIL-7R-M21, BD), anti-CCR7 FITC (150503, R&D), anti-CX3CR1
PerCP-Cy5.5 (2A9-1, Biolegend), anti-FasL AF488 (14C2, AbD Serotec), anti-NKG2D
PE-CF594 (1D11, BD Biosciences), anti-PD-1 PerCP-Cy5.5 (EH12.2H7, Biolegend) and anti-
Tim3 APC (F38-2E2, eBioscience). Following a final wash cells were re-suspended in 200 μL of
staining buffer for acquisition.
Intracellular staining. For detection of intracellular perforin and granzyme B, cells were
stained for surface antigens as described above, then fixed in 4% paraformaldehyde (Sigma-
Aldrich) for 15 minutes at RT in the dark. Cells were washed and anti-perforin PE-Cy7 (γG9,
eBioscience) and anti-granzyme B AF647 (GB11, Biolegend) antibodies were added in the pres-
ence of 0.5% saponin (Sigma-Aldrich) in PBS, incubated for 30 minutes at RT in the dark fol-
lowed by a washing step and re-suspended in 200 μL of staining buffer.
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For detection of intracellular FoxP3, cells were stained with surface markers as above and
after a washing step fixed for 30 minutes using 1X Fix/Perm buffer (eBioscience). Cells were
washed and then permeabilized in Perm buffer (eBioscience) for 15 minutes in the dark and
subsequently stained with anti-FoxP3 AF647 (206D, Biolegend) for 30 minutes at RT in the
dark before being washed and re-suspended in 200 μL of staining buffer.
All stained cells were acquired using an LSRII flow cytometer and DIVA software (BD Bio-
sciences) collecting at least 300,000 live lymphocytes and all data was processed using Kaluza
1.3 software (Beckman Coulter). For the analysis single, viable, CD14-CD19- lymphocytes
were gated on before selecting CD3+CD4+ T cells and CD3+CD4+tetramer+ cells which were
then further analysed for expression of surface and/or intracellular staining (S5 Fig). For multi-
colour staining panels additionally Boolean gating was used to identify all possible combina-
tions of markers stained for on CD3+CD4+ and CD3+CD4+tetramer+ T cell populations.
This data was further analysed using SPICE version 5.3 [76] and MultiExperiment viewer
(MeV) version 4.9 [77].
Peptide stimulation and intracellular cytokine staining
To identify cytokine-producing T cells following activation, 1x106 PBMC were resuspended in
RPMI1640 (Sigma-Aldrich) supplemented with 10% FCS and 1% Penicillin/Streptomycin and
stimulated with peptide (5μg/ml final concentration) overnight at 37°C with 5% CO2 in the
presence of BrefeldinA (10μg/ml final concentration; Sigma-Aldrich). Unstimulated cells and
cells stimulated with Staphylococcus Enterotoxin B (final concentration 0.2μg/ml; Sigma-
Aldrich) served as controls. Following overnight incubation the cells were stained with LIVE/
Dead fixable violet or aqua stain (Invitrogen) as described above, T-cells were then identified
by staining with anti-CD4-PE (RPA-T4, BD Bioscience) or anti-CD3 AF700 (SK7, Biolegend)
and anti-CD4 APC-Cy7 and B cells excluded by staining with anti-CD19 pacific blue (H1B19,
eBioscience; dump channel). Fixing was carried out with 4% paraformaldehyde (in PBS;
Sigma-Aldrich) for 15 min at RT before permeabilising with 0.5% Saponin (in PBS; Sigma-
Aldrich) for 5 min. Intracellular cytokines were then stained with the following antibodies:
anti-IFN-γ FITC antibody (25723.11, BD Bioscience) or anti-IFN-γ PE-Dazzle (4S.B3), anti-
TNF-α PE-Cy7 (Mab11), anti-IL-10 PE (JES3-9D7), anti-IL-4 BV421(MP4-25D2; all Biole-
gend), anti-IL17A (eBio64DEC17, eBioscience) and anti-MIP-1β (24006, R&D) and followed
by a final wash in staining buffer. Acquisition was carried out on an LSR II flow cytometer and
DIVA software (BD Bioscience) collecting 300,000 live lymphocytes and data analysed using
FlowJo software version 7.6.5 (Tree Star). For the analysis single, viable, CD19- lymphocytes
were gated before identification of cytokine-producing CD4+ T cells. For the multi-cytokine
panel Boolean gating was used to determine all possible combinations and further analysis was
carried out using SPICE version 5.3.
Cell separation and microarray analysis
To analyse the transcriptional profile of CMV-specific T cells we sorted DYS- and LLQ-specific
CD4+ T cells from CMV-seropositive healthy donors and for comparison CD4+ T cell subsets
from CMV-seronegative healthy individuals. For this PBMCs were isolated from 120 mL of
heparinised blood by density gradient centrifugation and the CD4+ T cell population was
enriched by negative selection (StemCell Technologies) according to manufacturer’s instruc-
tions. CD4+ T cells from CMV-seropositive donors were then stained with LIVE/Dead fixable
far red stain (Invitrogen), washed and re-suspended in 600 μL of human serum prior to incuba-
tion with PE-conjugated HLA class II tetramer (HLA-DR7:DYS or HLA-DQ6:LLQ) for 1 h at
37°C and 5% CO2. After washing, cells were stained with anti-CD4 PE-CF594 (RPA-T4, BD)
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and re-suspended in RPMI + 10% FCS. From the single, viable lymphocyte population CD4+
tetramer+ cells were then sorted on a MoFlow Cell Sorter (Beckman Coulter) consistently
reaching a purity of 98–99%. Following CD4-enrichment cells of CMV-seronegative donors
were stained with LIVE/Dead fixable far red stain (Invitrogen), anti-CD4 PE-CF594 (RPA-T4,
BD Biosciences), anti-CCR7 FITC (150503, R&D) and anti-CD45RA PE (HI100, eBioscience).
Based on their expression profile effector memory cells (CCR7-CD45RA-) were then sorted to
high purity.
Total RNA of the sorted cells was extracted using an RNeasy Plus Mini kit (Qiagen) accord-
ing to manufacturer’s instruction. The RNA integrity was checked and it was subsequently
labelled before hybridisation to Agilent human gene expression 8x60k microarrays (G4858A)
according to manufacturer’s instructions following the standard Agilent Low Input Quick
Amp labelling protocol. Due to low mRNA yield, CD4+CD45RO+ T cells sorted from a CMV-
seronegative donor served as the reference sample on the two-colour microarray slide. These
were not taken into account for the analysis. The Microarrays were carried out by the Func-
tional Genomics, Proteomics and Metabolomics Facility at the School of Biosciences, Univer-
sity of Birmingham.
Microarray data was analysed with the R Limma Package (Bioconductor) [78–80]. Normali-
sation was performed with the Loess (intra-array) and Aquantile (inter-array) methods. An
adjusted p-value (Benjamini and Hochberg's method) of 0.05 and below was taken as signifi-
cant for differences in gene expression or otherwise a 2-fold change in expression levels. Fur-
ther analysis of output data was completed in Excel (Microsoft Corp). Hierarchical clustering
was performed on the MultiExperiment viewer version 4.9 (MeV, [77]. Functional enrichment
analysis was completed using DAVID version 6.7 [81,82].
Microarray data are available in the ArrayExpress database (www.ebi.ac.uk/arrayexpress)
under accession number E-MTAB-4510.
Quantitative PCR to validate microarray findings
cDNA generated from the same samples used for the microarray analysis was used to analyse
transcription of a selected number of genes that were differentially expressed between CD4+EM
cells and CMV-specific CD4+ T cells. TaqMan Gene Expression Assays for CCL3 (Hs04194
942_s1), CCL4 (Hs04421399_gH), CCL5 (Hs00982282_m1), GZMB (Hs00188051_m1), PRF1
(Hs00169473_m1), ADRB2 (Hs00240532_s1), CX3CR1 (Hs04187059_m1) and GAPDH
(4310884E) were bought from Thermo Fisher Scientific. Specific target amplification was carried
out on the cDNA using 2× TaqMan PreAmpMaster Mix (Life Technologies) and 0.2× primer
mix (20× TaqMan assays diluted in water). Reactions were subjected to 95°C for 10 min, followed
by 12 cycles of 95°C for 15 s and 60°C for 4 min. These pre-amplified samples were then diluted
1:5 with water prior to Q-PCR analysis using the TaqMan Gene Expression Assays. The relative
transcription was calculated comparing with average transcription level of the three control
CD4+EM T cells and GAPDH assays served for normalization. Assays were performed in dupli-
cate for two to three donors each (EM, LLQ and DYS). Transcription levels in CD4+EM T cells
were set to 1.
Killing of target cells by CMV-specific CD4+ T cells
To analyse the cytotoxic capacity of CMV-specific CD4+ T cells directly ex vivo, CD4+TM+
cells were separated as described above and then co-cultured over night with CFSE labelled
(0.5μM; Invitrogen) autologous or HLA-matched LCLs which were loaded with the cognate
peptide. CFSE-labelled LCL alone served as control. In addition CD4+ CCR7-CD45RA- (EM)
cells of two CMV seronegative individuals were sorted and served as effector cells. Killing of
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target cells was assessed on a BD Accuri flow cytometer (BD Biosciences) by quantifying live
CFSE-labelled LCL using counterstaining with Propidium Iodide (PI) to identify dead cells. All
conditions were carried out in triplicate. For the analysis initially the T cell population and the
LCL population were gated on, using FSC and SSC scatter plots, to determine the true ratio of
effector to target cells. Then the number of live LCLs was determined using CFSE and PI and
percent killing of target cells was calculated.
Statistical analyses
Statistical analysis of flow cytometry data was performed using GraphPad Prism5. The non-
parametric Mann-Whitney U-test was applied for comparison of two groups, and the Kruskal-
Wallis test (with Dunn’s multiple comparison) for comparison of more than two groups of con-
tinuous measurements. To analyse the strength of associations between variables Spearman’s
rank test was used. A p-value of less than 0.05 was considered statistically significant.
Supporting Information
S1 Fig. Phenotype of total CD4+ T cell population. Cells were stained with CCR7, CD27,
CD28, CD57, CD45RA and CD45RO to characterise the overall phenotypic profile. Using
Boolean gating all possible combinations of the six surface markers were determined, and
those subsets containing cells categorised according to differentiation status (increasing from
left to right) as in Fig 3B. The heatmap is representing the proportion of CD4+ T cells within
each subset for each of the donors studied.
(TIF)
S2 Fig. Detection of regulatory T cells within CD4+ or TM+ populations. (A) Example scat-
ter plots showing co-expression of FoxP3 and CD25 on CD4+ or TM+ T cells. (B) Frequency
of FoxP3+CD25+ cells within the total CD4+ population or LLQ- AGI- or DYS-specific T
cells. Error bars indicate median with IQR.
(TIF)
S3 Fig. Proportion of CD4+ or TM+ T cells expressing FasL.
(TIF)
S4 Fig. Proportion of CD4+ or TM+ T cells expressing Tim-3.
(TIF)
S5 Fig. Gating strategy for flow cytometry analysis. Single cells were gated on (FSC-A vs
FSC-H), then live CD14-CD19- cells, before identifying the lymphocyte population (FSC-A vs
SSC-A). Of these CD3+CD4+ T cells gated on and within those HLA class II-peptide TM+
cells.
(TIF)
S1 Table. Genes at least 2-fold up or down regulated in CMV-specific CD4+ T cells com-
pared to EM CD4+ T cells.
(XLSX)
S2 Table. Genes differentially expressed between DYS-specific CD4+ T cells and EM CD4+
T cells.
(XLSX)
S3 Table. Genes at least 2-fold up or down regulated in LLQ-specific CD4+ T cells com-
pared to EM CD4+ T cells.
(XLSX)
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